[Skip to Content]
Radiation Oncology

Video Editor's Note: Radiotherapy With vs Without Chemoradiotherapy in Low-risk Nasopharyngeal Carcinoma

JAMA
Published Online: August 23, 2022 Video 4 min 2 sec

JAMA Associate Editor Ethan Basch, MD, gives editorial insight into a randomized clinical trial investigating the effect of radiotherapy with vs without chemoradiotherapy in patients with low-risk nasopharyngeal carcinoma.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Related Articles

  1. Radiotherapy With vs Without Chemoradiotherapy and Survival Without Disease Relapse in Low-risk Nasopharyngeal Carcinoma

See More About

Head and Neck Cancer Oncology Otolaryngology Radiation Oncology
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue